Australia warns against counterfeit rabies vaccine in India: What advisory says and how 'Abhayrab' manufacturer reacted
ATAGI advised Australian travelers who received the Abhayrab vaccine in India after November 1, 2023, to restart immunisation due to counterfeit concerns. The manufacturer, IIL, clarified that the issue involves a specific batch and urged ATAGI to reconsider its advisory to avoid public anxiety.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
